Skip to main content
Top
Published in: Journal of Neurology 4/2016

01-04-2016 | Review

“Orbiting around” the orbital myositis: clinical features, differential diagnosis and therapy

Authors: F. Montagnese, S. Wenninger, B. Schoser

Published in: Journal of Neurology | Issue 4/2016

Login to get access

Abstract

Orbital myositis (OM) is a rare disease whose clinical heterogeneity and different treatment options represent a diagnostic and therapeutic challenge. We aim to review the state of knowledge on OM, also describing a cohort of patients diagnosed in our centre, to highlight some remarkable clinical features. A literature review was conducted in PubMed and Medline databases. The herein described cohort is composed of seven OM patients, diagnosed according to clinical, laboratory and neuroradiological features, whose clinical data were retrospectively analysed. OM is a non-infectious, inflammatory process primarily involving extraocular eye-muscles. It typically presents as an acute to sub-acute, painful ophthalmoplegia with signs of ocular inflammation, but atypical cases without pain or with a chronic progression have been described. The wide range of OM mimicking diseases make a prompt diagnosis challenging but orbit MRI provides valuable clues for differential diagnosis. Timely treatment is greatly important as OM promptly responds to steroids; nevertheless, partial recovery or relapses often occur. In refractory, recurrent or steroid-intolerant cases other therapeutic options (radiotherapy, immunosuppressants, immunoglobulins) can be adopted, but the most effective therapeutic management is yet to be established. In this review, we provide a detailed clinical description of OM, considering the main differential diagnoses and suggesting the most useful investigations. In light of the currently available data on therapy efficacy, we propose a therapeutic algorithm that may guide neurologists in OM patients’ management.
Literature
1.
go back to reference Yuen SJ, Rubin PA (2003) Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol 121:491–499CrossRefPubMed Yuen SJ, Rubin PA (2003) Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol 121:491–499CrossRefPubMed
2.
go back to reference Harris GJ (2006) Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy: the 2005 ASOPRS Foundation Lecture. Ophthal Plast Reconstr Surg 22:79–86CrossRefPubMed Harris GJ (2006) Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy: the 2005 ASOPRS Foundation Lecture. Ophthal Plast Reconstr Surg 22:79–86CrossRefPubMed
3.
go back to reference Dalakas MC (2006) Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Neuromuscul Disord 16(4):223–236CrossRefPubMed Dalakas MC (2006) Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Neuromuscul Disord 16(4):223–236CrossRefPubMed
4.
5.
go back to reference Siatkowski RM, Capó H, Byrne SF et al (1994) Clinical and echographic findings in idiopathic orbital myositis. Am J Ophthalmol 118:343–350CrossRefPubMed Siatkowski RM, Capó H, Byrne SF et al (1994) Clinical and echographic findings in idiopathic orbital myositis. Am J Ophthalmol 118:343–350CrossRefPubMed
6.
go back to reference Mombaerts I, Koornneef L (1997) Current status in the treatment of orbital myositis. Ophthalmology 104:402–408CrossRefPubMed Mombaerts I, Koornneef L (1997) Current status in the treatment of orbital myositis. Ophthalmology 104:402–408CrossRefPubMed
8.
go back to reference Ota M, Shimizu T, Yoshida H et al (2014) Clinical features and therapeutic responses of idiopathic orbital myositis. Neurol Clin Neurosci 3:63–67CrossRef Ota M, Shimizu T, Yoshida H et al (2014) Clinical features and therapeutic responses of idiopathic orbital myositis. Neurol Clin Neurosci 3:63–67CrossRef
9.
go back to reference Avni-Zauberman N, Tripathy D, Rosen N, Ben Simon GJ (2012) Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature. Br J Ophthalmol 96:276–280CrossRefPubMed Avni-Zauberman N, Tripathy D, Rosen N, Ben Simon GJ (2012) Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature. Br J Ophthalmol 96:276–280CrossRefPubMed
10.
go back to reference Spindle J, Narang S, Purewal B, Shinder R (2013) Atypical idiopathic orbital inflammation in a young girl. Ophthal Plast Reconstr Surg 29:86–88CrossRef Spindle J, Narang S, Purewal B, Shinder R (2013) Atypical idiopathic orbital inflammation in a young girl. Ophthal Plast Reconstr Surg 29:86–88CrossRef
11.
go back to reference Gori S, Lucchesi C, Calabrese R et al (2013) Inferior rectus myositis: a rare cause of painful ophthalmoplegia and a therapeutic challenge. Neurol Sci 34:789–791CrossRefPubMed Gori S, Lucchesi C, Calabrese R et al (2013) Inferior rectus myositis: a rare cause of painful ophthalmoplegia and a therapeutic challenge. Neurol Sci 34:789–791CrossRefPubMed
12.
go back to reference Sahlin S, Lignell B, Williams M, Dastmalchi M, Orrego A (2009) Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab. Acta Ophthalmol 87:906–908CrossRefPubMed Sahlin S, Lignell B, Williams M, Dastmalchi M, Orrego A (2009) Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab. Acta Ophthalmol 87:906–908CrossRefPubMed
13.
go back to reference Garcia-Pous M, Hernández-Garfella ML, Díaz-Llopis M (2007) Treatment of chronic orbital myositis with daclizumab. Can J Ophthalmol 42:156–157CrossRefPubMed Garcia-Pous M, Hernández-Garfella ML, Díaz-Llopis M (2007) Treatment of chronic orbital myositis with daclizumab. Can J Ophthalmol 42:156–157CrossRefPubMed
14.
go back to reference Hernández-Garfella ML, Gracia-García A, Cervera-Taulet E, García-Villanueva C, Montero-Hernández J (2011) Adalimumab for recurrent orbital myositis in Crohn’s disease: report of a case with a 3-year follow-up. J Crohns Colitis 5:265–266CrossRefPubMed Hernández-Garfella ML, Gracia-García A, Cervera-Taulet E, García-Villanueva C, Montero-Hernández J (2011) Adalimumab for recurrent orbital myositis in Crohn’s disease: report of a case with a 3-year follow-up. J Crohns Colitis 5:265–266CrossRefPubMed
15.
go back to reference Mannor GE, Rose GE, Moseley IF, Wright JE (1997) Outcome of orbital myositis. Clinical features associated with recurrence. Ophthalmology 104:409–414CrossRefPubMed Mannor GE, Rose GE, Moseley IF, Wright JE (1997) Outcome of orbital myositis. Clinical features associated with recurrence. Ophthalmology 104:409–414CrossRefPubMed
17.
go back to reference Fraser CL, Skalicky SE, Gurbaxani A, McCluskey P (2013) Ocular myositis. Curr Allergy Asthma Rep 13:315–321CrossRefPubMed Fraser CL, Skalicky SE, Gurbaxani A, McCluskey P (2013) Ocular myositis. Curr Allergy Asthma Rep 13:315–321CrossRefPubMed
18.
go back to reference Schoser B (2007) Ocular myositis: diagnostic assessment, differential diagnoses, and therapy of a rare muscle disease—five new cases and review. Clin Ophthalmol 1:37–42PubMedPubMedCentral Schoser B (2007) Ocular myositis: diagnostic assessment, differential diagnoses, and therapy of a rare muscle disease—five new cases and review. Clin Ophthalmol 1:37–42PubMedPubMedCentral
19.
go back to reference Peter J, Andrew NH, Smith C, Figueira E, Selva D (2014) Idiopathic inflammatory orbital myositis presenting with vision loss. Orbit 33:449–452CrossRefPubMed Peter J, Andrew NH, Smith C, Figueira E, Selva D (2014) Idiopathic inflammatory orbital myositis presenting with vision loss. Orbit 33:449–452CrossRefPubMed
20.
go back to reference Tieleman AA, den Broeder AA, van de Logt AE, van Engelen BG (2009) Strong association between myotonic dystrophy type 2 and autoimmune diseases. J Neurol Neurosurg Psychiatry 80:1293–1295CrossRefPubMed Tieleman AA, den Broeder AA, van de Logt AE, van Engelen BG (2009) Strong association between myotonic dystrophy type 2 and autoimmune diseases. J Neurol Neurosurg Psychiatry 80:1293–1295CrossRefPubMed
21.
go back to reference Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ (2012) Ophthalmoplegic “migraine” or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol 27:759–766CrossRefPubMedPubMedCentral Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ (2012) Ophthalmoplegic “migraine” or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol 27:759–766CrossRefPubMedPubMedCentral
22.
go back to reference Petzold A, Wattjes MP, Costello F et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10:447–458CrossRefPubMed Petzold A, Wattjes MP, Costello F et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10:447–458CrossRefPubMed
23.
go back to reference McNab AA, McKelvie P (2015) IgG4-related ophthalmic disease. Part II: clinical aspects. Ophthal Plast Reconstr Surg 31:167–178CrossRefPubMed McNab AA, McKelvie P (2015) IgG4-related ophthalmic disease. Part II: clinical aspects. Ophthal Plast Reconstr Surg 31:167–178CrossRefPubMed
24.
go back to reference Chaudhry IA, Elkhamry SM, Al-Rashed W, Bosley TM (2009) Carotid cavernous fistula: ophthalmological implications. Middle East Afr J Ophthalmol 16:57–63CrossRefPubMedPubMedCentral Chaudhry IA, Elkhamry SM, Al-Rashed W, Bosley TM (2009) Carotid cavernous fistula: ophthalmological implications. Middle East Afr J Ophthalmol 16:57–63CrossRefPubMedPubMedCentral
25.
go back to reference Preechawat P, Narmkerd P, Jiarakongmun P, Poonyathalang A, Pongpech SM (2008) Dural carotid cavernous sinus fistula: ocular characteristics, endovascular management and clinical outcome. J Med Assoc Thai 91:852–858PubMed Preechawat P, Narmkerd P, Jiarakongmun P, Poonyathalang A, Pongpech SM (2008) Dural carotid cavernous sinus fistula: ocular characteristics, endovascular management and clinical outcome. J Med Assoc Thai 91:852–858PubMed
26.
go back to reference Rodrigues T, Willinsky R, Agid R, TerBrugge K, Krings T (2014) Management of dural carotid cavernous fistulas: a single-centre experience. Eur Radiol 24:3051–3058CrossRefPubMed Rodrigues T, Willinsky R, Agid R, TerBrugge K, Krings T (2014) Management of dural carotid cavernous fistulas: a single-centre experience. Eur Radiol 24:3051–3058CrossRefPubMed
27.
28.
go back to reference Sauer A, Speeg-Schatz C, Hansmann Y (2011) Two cases of orbital myositis as a rare feature of lyme borreliosis. Case Rep Infect Dis 2011:372470PubMedPubMedCentral Sauer A, Speeg-Schatz C, Hansmann Y (2011) Two cases of orbital myositis as a rare feature of lyme borreliosis. Case Rep Infect Dis 2011:372470PubMedPubMedCentral
29.
go back to reference Patheja RS, Weaver T, Morris S (2015) Unique case of orbital myositis and dacryoadenitis preceding the vesicular rash of Herpes zoster ophthalmicus. Clin Exp Ophthalmol. doi:10.1111/ceo.12584 Patheja RS, Weaver T, Morris S (2015) Unique case of orbital myositis and dacryoadenitis preceding the vesicular rash of Herpes zoster ophthalmicus. Clin Exp Ophthalmol. doi:10.​1111/​ceo.​12584
30.
go back to reference Mavrikakis I, Rootman J (2007) Diverse clinical presentations of orbital sarcoid. Am J Ophthalmol 144:769–775CrossRefPubMed Mavrikakis I, Rootman J (2007) Diverse clinical presentations of orbital sarcoid. Am J Ophthalmol 144:769–775CrossRefPubMed
31.
go back to reference Salam A, Meligonis G, Malhotra R (2008) Superior oblique myositis as an early feature of orbital Wegener’s granulomatosis. Orbit 27:203–206CrossRefPubMed Salam A, Meligonis G, Malhotra R (2008) Superior oblique myositis as an early feature of orbital Wegener’s granulomatosis. Orbit 27:203–206CrossRefPubMed
32.
go back to reference Arrico L, Abbouda A, Bianchi S, Malagola R (2014) Acute monolateral proptosis and orbital myositis in a patient with discoid lupus erythematosus: a case report. J Med Case Rep 8:375CrossRefPubMedPubMedCentral Arrico L, Abbouda A, Bianchi S, Malagola R (2014) Acute monolateral proptosis and orbital myositis in a patient with discoid lupus erythematosus: a case report. J Med Case Rep 8:375CrossRefPubMedPubMedCentral
33.
go back to reference Verma S, Kroeker KI, Fedorak RN (2013) Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature. BMC Gastroenterol 13:59CrossRefPubMedPubMedCentral Verma S, Kroeker KI, Fedorak RN (2013) Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature. BMC Gastroenterol 13:59CrossRefPubMedPubMedCentral
34.
go back to reference Sogabe Y, Ohshima K, Azumi A et al (2014) Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol 252:531–538CrossRefPubMed Sogabe Y, Ohshima K, Azumi A et al (2014) Location and frequency of lesions in patients with IgG4-related ophthalmic diseases. Graefes Arch Clin Exp Ophthalmol 252:531–538CrossRefPubMed
35.
go back to reference Deschamps R, Deschamps L, Depaz R et al (2013) High prevalence of IgG4-related lymphoplasmacytic infiltrative disorder in 25 patients with orbital inflammation: a retrospective case series. Br J Ophthalmol 97:999–1004CrossRefPubMed Deschamps R, Deschamps L, Depaz R et al (2013) High prevalence of IgG4-related lymphoplasmacytic infiltrative disorder in 25 patients with orbital inflammation: a retrospective case series. Br J Ophthalmol 97:999–1004CrossRefPubMed
36.
37.
go back to reference Khosroshahi A, Carruthers MN, Deshpande V et al (2012) Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Med (Baltim) 91:57–66CrossRef Khosroshahi A, Carruthers MN, Deshpande V et al (2012) Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Med (Baltim) 91:57–66CrossRef
38.
go back to reference Gordon LK (2006) Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye (Lond) 20(10):1196–1206CrossRef Gordon LK (2006) Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye (Lond) 20(10):1196–1206CrossRef
39.
go back to reference Lazarus JH (2012) Epidemiology of Graves’ orbitopathy, (GO) and relationship with thyroid disease. Best Pract Res Clin Endocrinol Metab 26:273–279CrossRefPubMed Lazarus JH (2012) Epidemiology of Graves’ orbitopathy, (GO) and relationship with thyroid disease. Best Pract Res Clin Endocrinol Metab 26:273–279CrossRefPubMed
40.
go back to reference Ponto KA, Kanitz M, Olivo PD, Pitz S, Pfeiffer N, Kahaly GJ (2011) Clinical relevance of thyroid-stimulating immunoglobulins in graves’ ophthalmopathy. Ophthalmology 118:2279–2285CrossRefPubMed Ponto KA, Kanitz M, Olivo PD, Pitz S, Pfeiffer N, Kahaly GJ (2011) Clinical relevance of thyroid-stimulating immunoglobulins in graves’ ophthalmopathy. Ophthalmology 118:2279–2285CrossRefPubMed
41.
go back to reference Zöphel K, Roggenbuck D, Schott M (2010) Clinical review about TRAb assay’s history. Autoimmun Rev 9:695–700CrossRefPubMed Zöphel K, Roggenbuck D, Schott M (2010) Clinical review about TRAb assay’s history. Autoimmun Rev 9:695–700CrossRefPubMed
42.
go back to reference Kan E, Kan EK, Ecemis G, Colak R (2014) Presence of thyroid-associated ophthalmopathy in Hashimoto’s thyroiditis. Int J Ophthalmol 7:644–647PubMedPubMedCentral Kan E, Kan EK, Ecemis G, Colak R (2014) Presence of thyroid-associated ophthalmopathy in Hashimoto’s thyroiditis. Int J Ophthalmol 7:644–647PubMedPubMedCentral
44.
go back to reference Perros P, Žarković M, Azzolini C et al (2015) PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012. Br J Ophthalmol. doi:10.1136/bjophthalmol-2015-306733 PubMed Perros P, Žarković M, Azzolini C et al (2015) PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012. Br J Ophthalmol. doi:10.​1136/​bjophthalmol-2015-306733 PubMed
45.
go back to reference Nutting CM, Jenkins CD, Norton AJ, Cree I, Rose GE, Plowman PN (2002) Primary orbital lymphoma. Hematol J 3:14–16CrossRefPubMed Nutting CM, Jenkins CD, Norton AJ, Cree I, Rose GE, Plowman PN (2002) Primary orbital lymphoma. Hematol J 3:14–16CrossRefPubMed
46.
go back to reference Nagia L, Lemos J, Abusamra K, Cornblath WT, Eggenberger ER (2015) Prognosis of ocular myasthenia gravis: retrospective multicenter analysis. Ophthalmology 122:1517–1521CrossRefPubMed Nagia L, Lemos J, Abusamra K, Cornblath WT, Eggenberger ER (2015) Prognosis of ocular myasthenia gravis: retrospective multicenter analysis. Ophthalmology 122:1517–1521CrossRefPubMed
47.
go back to reference MacLennan C, Beeson D, Buijs AM, Vincent A, Newsom-Davis J (1997) Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol 41:423–431CrossRefPubMed MacLennan C, Beeson D, Buijs AM, Vincent A, Newsom-Davis J (1997) Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann Neurol 41:423–431CrossRefPubMed
48.
go back to reference Tsivgoulis G, Dervenoulas G, Kokotis P et al (2014) Double seronegative myasthenia gravis with low density lipoprotein-4 (LRP4) antibodies presenting with isolated ocular symptoms. J Neurol Sci 346:328–330CrossRefPubMed Tsivgoulis G, Dervenoulas G, Kokotis P et al (2014) Double seronegative myasthenia gravis with low density lipoprotein-4 (LRP4) antibodies presenting with isolated ocular symptoms. J Neurol Sci 346:328–330CrossRefPubMed
49.
go back to reference Kerty E, Elsais A, Argov Z, Evoli A, Gilhus NE (2014) EFNS/ENS Guidelines for the treatment of ocular myasthenia. Eur J Neurol 21:687–693CrossRefPubMed Kerty E, Elsais A, Argov Z, Evoli A, Gilhus NE (2014) EFNS/ENS Guidelines for the treatment of ocular myasthenia. Eur J Neurol 21:687–693CrossRefPubMed
50.
go back to reference Witting N, Mensah A, Køber L et al (2014) Ocular, bulbar, limb, and cardiopulmonary involvement in oculopharyngeal muscular dystrophy. Acta Neurol Scand 130:125–130CrossRefPubMed Witting N, Mensah A, Køber L et al (2014) Ocular, bulbar, limb, and cardiopulmonary involvement in oculopharyngeal muscular dystrophy. Acta Neurol Scand 130:125–130CrossRefPubMed
51.
go back to reference Mancuso M, Orsucci D, Angelini C et al (2015) Redefining phenotypes associated with mitochondrial DNA single deletion. J Neurol 262:1301–1309CrossRefPubMed Mancuso M, Orsucci D, Angelini C et al (2015) Redefining phenotypes associated with mitochondrial DNA single deletion. J Neurol 262:1301–1309CrossRefPubMed
52.
53.
go back to reference Kirsch E, Hammer B, Arx G (2009) Grave’s orbitopathy: current imaging procedures. Swiss Med Wkly 139(43–44):618–623PubMed Kirsch E, Hammer B, Arx G (2009) Grave’s orbitopathy: current imaging procedures. Swiss Med Wkly 139(43–44):618–623PubMed
54.
go back to reference Moon WJ, Na DG, Ryoo JW et al (2003) Orbital lymphoma and subacute or chronic inflammatory pseudotumor: differentiation with two-phase helical computed tomography. J Comput Assist Tomogr 27:510–516CrossRefPubMed Moon WJ, Na DG, Ryoo JW et al (2003) Orbital lymphoma and subacute or chronic inflammatory pseudotumor: differentiation with two-phase helical computed tomography. J Comput Assist Tomogr 27:510–516CrossRefPubMed
55.
go back to reference Fatima Z, Ichikawa T, Ishigame K et al (2014) Orbital masses: the usefulness of diffusion-weighted imaging in lesion categorization. Clin Neuroradiol 24:129–134CrossRefPubMed Fatima Z, Ichikawa T, Ishigame K et al (2014) Orbital masses: the usefulness of diffusion-weighted imaging in lesion categorization. Clin Neuroradiol 24:129–134CrossRefPubMed
56.
go back to reference Kau HC, Kao SC, Peng CH, Hsu WM, Tsai CC (2006) Methylprednisolone pulse therapy in patient with isolated superior oblique myositis. Eye (Lond) 20:1106–1109CrossRef Kau HC, Kao SC, Peng CH, Hsu WM, Tsai CC (2006) Methylprednisolone pulse therapy in patient with isolated superior oblique myositis. Eye (Lond) 20:1106–1109CrossRef
57.
go back to reference El Nasser A, Mohammad A (2013) Local steroid injection for management of different types of acute idiopathic orbital inflammation: an 8-year study. Ophthal Plast Reconstr Surg 29:286–289CrossRef El Nasser A, Mohammad A (2013) Local steroid injection for management of different types of acute idiopathic orbital inflammation: an 8-year study. Ophthal Plast Reconstr Surg 29:286–289CrossRef
58.
go back to reference Wong JK, Lee JW, Yuen CY (2014) Re: “Local steroid injection for management of different types of acute idiopathic orbital inflammation: an 8-year study”. Ophthal Plast Reconstr Surg 30:532CrossRefPubMed Wong JK, Lee JW, Yuen CY (2014) Re: “Local steroid injection for management of different types of acute idiopathic orbital inflammation: an 8-year study”. Ophthal Plast Reconstr Surg 30:532CrossRefPubMed
59.
60.
go back to reference Matthiesen C, Bogardus C Jr, Thompson JS et al (2011) The efficacy of radiotherapy in the treatment of orbital pseudotumor. Int J Radiat Oncol Biol Phys 79:1496–1502CrossRefPubMed Matthiesen C, Bogardus C Jr, Thompson JS et al (2011) The efficacy of radiotherapy in the treatment of orbital pseudotumor. Int J Radiat Oncol Biol Phys 79:1496–1502CrossRefPubMed
61.
go back to reference Bau V, Sievert M, Roggenkämper P, Zierz S (2005) Cyclic vertical deviation after ocular myositis and treatment by recession of the inferior rectus muscle. Graefes Arch Clin Exp Ophthalmol 243:1062–1065CrossRefPubMed Bau V, Sievert M, Roggenkämper P, Zierz S (2005) Cyclic vertical deviation after ocular myositis and treatment by recession of the inferior rectus muscle. Graefes Arch Clin Exp Ophthalmol 243:1062–1065CrossRefPubMed
62.
go back to reference Bessant DA, Lee JP (1995) Management of strabismus due to orbital myositis. Eye (Lond) 9:558–563CrossRef Bessant DA, Lee JP (1995) Management of strabismus due to orbital myositis. Eye (Lond) 9:558–563CrossRef
63.
go back to reference Bunting HJ, Dawson EL, Lee JP, Adams GG (2013) Role of inferior rectus botulinum toxin injection in vertical strabismus resulting from orbital pathology. Strabismus 21:165–168CrossRefPubMed Bunting HJ, Dawson EL, Lee JP, Adams GG (2013) Role of inferior rectus botulinum toxin injection in vertical strabismus resulting from orbital pathology. Strabismus 21:165–168CrossRefPubMed
Metadata
Title
“Orbiting around” the orbital myositis: clinical features, differential diagnosis and therapy
Authors
F. Montagnese
S. Wenninger
B. Schoser
Publication date
01-04-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 4/2016
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7926-x

Other articles of this Issue 4/2016

Journal of Neurology 4/2016 Go to the issue